Innoviva INVA
NASDAQ INVA
$21.33 -0.02 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Innoviva (INVA) Finished Goods (2013 - 2026)

Innoviva's (INVA) quarterly Finished Goods came in at $4.1 million in Q1 2026, up 18.17% YoY from $3.4 million in Q1 2025, and down 18.35% on a QoQ basis from $5.0 million in Q4 2025.

Analysis

Innoviva (INVA) Finished Goods (2013 - 2026) Analysis & Trends

Innoviva (INVA) has 7 years of Finished Goods data on file, last reported at $4.1 million in Q1 2026.

  • Quarterly Finished Goods rose 18.17% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 million (up 18.17% YoY) and the FY2025 annual result came in at $5.0 million, up 138.65% from the prior year.
  • Finished Goods eased to $4.1 million in Q1 2026, from $5.0 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $25.1 million in Q4 2022 to a low of $2.1 million in Q4 2024.
  • A 5-year average of $9.6 million and a median of $5.3 million in 2025 frame the typical range for Finished Goods.
  • Annual changes were most pronounced in 2024 — Finished Goods sank 84.92% — and 2025, when it surged 138.65%.
  • Tracing INVA's Finished Goods over 5 years: stood at $25.1 million in 2022, then plunged by 44.95% to $13.8 million in 2023, then tumbled by 84.92% to $2.1 million in 2024, then surged by 138.65% to $5.0 million in 2025, then slipped by 18.35% to $4.1 million in 2026.
  • The last three Finished Goods figures came in at $4.1 million (Q1 2026), $5.0 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Innoviva 1.56 Bn 984.81 Mn 90.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.12 Mn
Mar 31, 2026 4.06 Mn
Dec 31, 2025 4.97 Mn
Sep 30, 2025 5.32 Mn
Jun 30, 2025 4.30 Mn
Mar 31, 2025 3.44 Mn
Dec 31, 2024 2.08 Mn
Sep 30, 2024 4.31 Mn
Jun 30, 2024 4.34 Mn
Mar 31, 2024 7.72 Mn
Dec 31, 2023 13.81 Mn
Sep 30, 2023 18.43 Mn
Jun 30, 2023 14.12 Mn
Mar 31, 2023 21.36 Mn
Dec 31, 2022 25.09 Mn
Sep 30, 2022 10.92 Mn
Mar 31, 2014 4.79 Mn
Dec 31, 2013 4.91 Mn
Sep 30, 2013 1.35 Mn